EP0833904A4 - Facteur de croissance des fibroblastes 14 - Google Patents

Facteur de croissance des fibroblastes 14

Info

Publication number
EP0833904A4
EP0833904A4 EP95921454A EP95921454A EP0833904A4 EP 0833904 A4 EP0833904 A4 EP 0833904A4 EP 95921454 A EP95921454 A EP 95921454A EP 95921454 A EP95921454 A EP 95921454A EP 0833904 A4 EP0833904 A4 EP 0833904A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
fibroblast growth
fibroblast
factor
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95921454A
Other languages
German (de)
English (en)
Other versions
EP0833904A1 (fr
Inventor
John M Greene
Patrick J Dillon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0833904A1 publication Critical patent/EP0833904A1/fr
Publication of EP0833904A4 publication Critical patent/EP0833904A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP95921454A 1995-06-05 1995-06-05 Facteur de croissance des fibroblastes 14 Withdrawn EP0833904A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/006730 WO1996039506A1 (fr) 1995-06-05 1995-06-05 Facteur de croissance des fibroblastes 14
CA002212992A CA2212992A1 (fr) 1995-06-05 1995-06-05 Facteur de croissance des fibroblastes 14

Publications (2)

Publication Number Publication Date
EP0833904A1 EP0833904A1 (fr) 1998-04-08
EP0833904A4 true EP0833904A4 (fr) 2000-05-17

Family

ID=25679546

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921454A Withdrawn EP0833904A4 (fr) 1995-06-05 1995-06-05 Facteur de croissance des fibroblastes 14

Country Status (4)

Country Link
EP (1) EP0833904A4 (fr)
AU (1) AU702131B2 (fr)
CA (1) CA2212992A1 (fr)
WO (1) WO1996039506A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions et methodes de traitement de maladies liees a l'immunite
US6787640B2 (en) 1995-06-05 2004-09-07 Human Genome Sciences, Inc. Fibroblast growth factor 14
CA2249179A1 (fr) * 1996-03-21 1997-09-25 The Johns Hopkins University School Of Medicine Facteur 3 homologue du facteur de croissance des fibroblastes (fhf-3) et procedes d'utilisation
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
CN1311212A (zh) * 2000-03-02 2001-09-05 上海博德基因开发有限公司 一种新的多肽——人成纤维细胞生长因子14和编码这种多肽的多核苷酸
US8026088B2 (en) 2005-12-02 2011-09-27 The Scripps Research Institute Angiogenic tyrosyl tRNA synthetase compositions and methods
KR20130102534A (ko) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
EP2814514B1 (fr) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-arnt synthétases pour le traitement de maladies auto-immunes et inflammatoires
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
CA3060514A1 (fr) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions et procedes pour le traitement d'inflammation pulmonaire

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002131010, Database accession no. T27215 *
GALZIE Z. ET AL: "Fibroblast growth factors and their receptors", BIOCHEM. CELL BIOL., vol. 75, 1997, pages 669 - 685, XP002144481, DOI: doi:10.1139/bcb-75-6-669 *
GOSPODAROWICZ, D.: "Fibroblast growth factors: from genes to clinical applications", CELL BIOLOGY REVIEWS, vol. 25, no. 4, 1991, pages 307 - 314, XP002058994 *
See also references of WO9639506A1 *
SMALLWOOD, P.M. ET AL.: "Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, no. 18, 3 September 1996 (1996-09-03), pages 9850 - 9857, XP002058996 *
SZEBENYI G.; FALLON F.: "Fibroblast growth factors as multifunctional signaling factors", INTERNATIONAL REVIEW OF CYTOLOGY, vol. 185, 1999, pages 45 - 106, XP001038510 *

Also Published As

Publication number Publication date
EP0833904A1 (fr) 1998-04-08
AU702131B2 (en) 1999-02-11
CA2212992A1 (fr) 1996-12-12
WO1996039506A1 (fr) 1996-12-12
AU2653095A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
NO982991D0 (no) Veksthormon-sekretagoguer
FI963475L (fi) Fibroblastin kasvutekijä 10
EP0871705A4 (fr) Facteur de croissance humain du type ccn
EP0725796A4 (fr) Facteur 10 de la differentiation de croissance
EP0717633A4 (fr) Facteur 7 de differenciation de la croissance
DE59509539D1 (de) Zwischenwirbel-implantat
FR2729291B1 (fr) Implant rachidien
DE59605821D1 (de) l/4-SCALLABSORBER
DE69622773D1 (de) Hüftpfanne
EP1062319A4 (fr) Facteur de croissance endothelial vasculaire 2
FR2735198B1 (fr) Piece d'accastillage de type manille-cosse
DE59610160D1 (de) Verstellring
DK0724826T3 (da) Urtepotte
DE69605683D1 (de) Lebensmitteldressing
EP0833904A4 (fr) Facteur de croissance des fibroblastes 14
EP0832215A4 (fr) Facteur 11 de croissance des fibroblastes
FI954252A7 (fi) Luukasvutekijä
FR2727855B1 (fr) Implants d'extension caverneuse
IL112924A0 (en) Easel
EP0832216A4 (fr) Facteur 15 de croissance des fibroblastes
NO960353L (no) 4-aminobenzoylguanidinderivater
FI933949L (fi) Implantat
EP1100887A4 (fr) Facteur 11 de differentiation de croissance
EP0833892A4 (fr) Facteur de croissance de type 2 derive de l'hepatome humain
NO960392D0 (no) 4-merkaptobenzoylguanidinderivater

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000329

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20010806

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

APAA Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050225

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE